Increasing availability of benzodiazepines among people who inject drugs in a Canadian setting

References

• Cunningham CM, Hanley GE, Morgan S. Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use. Health Policy. 2010;97:122–129.
   PubMed Web of Science ®Google Scholar
• Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry. 2015;72:136–142.
   PubMed Web of Science ®Google Scholar
• National Advisory Committee on Prescription Drug Misuse. (2013). First do no harm: Responding to Canada's prescription drug crisis. Ottawa: Canadian Centre on Substance Abuse. (http://www.ccsa.ca/Resource%20Library/Canada-Strategy-Prescription-Drug-Misuse-Report-en.pdf)
   Google Scholar
• I-Track: Enhanced Surveillance of HIV, Hepatitis C and Associated Risk Behaviours Among Pople Who Inject Drugs in Canada. Phase 2 Report. Ottawa, Ontario: Center for Communicable Disease and Infection Control, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada; 2013.
   Google Scholar
• Khosla N, Juon HS, Kirk GD, Astemborski J, Mehta SH. Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City. Addict Behav. 2011;36:1282–1287.
   PubMed Web of Science ®Google Scholar
• Nosyk B, Marshall BD, Fischer B, Montaner JS, Wood E, Kerr T. Increases in the availability of prescribed opioids in a Canadian setting. Drug Alcohol Depend. 2012 Nov 1;126(1-2):7–12.
   PubMed Web of Science ®Google Scholar
• Barker MJ, Greenwood KM, Jackson M, Crowe SF. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol. 2004;19:437–454.
   PubMed Web of Science ®Google Scholar
• Smink BE, Egberts AC, Lusthof KJ, Uges DR, de Gier JJ. The relationship between benzodiazepine use and traffic accidents: a systematic literature review. CNS Drugs. 2010;24:639–653.
   PubMed Web of Science ®Google Scholar
• Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs. 2003;17:825–837.
   PubMed Web of Science ®Google Scholar
• Licata SC, Rowlett JK. Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav. 2008;90:74–89.
   PubMed Web of Science ®Google Scholar
• Bach P, Walton G, Hayashi K, et al. Benzodiazepine use and hepatitis C seroconversion in a cohort of persons who inject drugs. Am J Public Health. 2016;106:1067–1072.
   PubMed Web of Science ®Google Scholar
• Ickowicz S, Hayashi K, Dong H, et al. Benzodiazepine use as an independent risk factor for HIV infection in a Canadian setting. Drug Alcohol Depend. 2015;155:190–194.
   PubMed Web of Science ®Google Scholar
• Bleich A, Gelkopf M, Schmidt V, Hayward R, Bodner G, Adelson M. Correlates of benzodiazepine abuse in methadone maintenance treatment. A 1 year prospective study in an Israeli clinic. Addiction. 1999;94:1533–1540.
   PubMed Web of Science ®Google Scholar
• Ross J, Darke S. The nature of benzodiazepine dependence among heroin users in Sydney, Australia. Addiction. 2000;95:1785–1793.
   PubMed Web of Science ®Google Scholar
• Kerr T, Fairbairn N, Tyndall M, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87:39–45.
   PubMed Web of Science ®Google Scholar
• Fischer B, Brissette S, Brochu S, et al. Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ. 2004;171:235–239.
   PubMed Web of Science ®Google Scholar
• Zamparutti G, Schifano F, Corkery JM, Oyefeso A, Ghodse AH. Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997–2007. Br J Clin Pharmacol. 2011;72:330–337.
   PubMed Web of Science ®Google Scholar
• Shah R, Uren Z, Baker A, Majeed A. Trends in deaths from drug overdose and poisoning in England and Wales 1993–1998. J Public Health Med. 2001;23:242–246.
   PubMedGoogle Scholar
• Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 2013;131:263–270.
   PubMed Web of Science ®Google Scholar
• Charlson F, Degenhardt L, McLaren J, Hall W, Lynskey M. A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf. 2009;18:93–103.
   PubMed Web of Science ®Google Scholar
• Leece P, Cavacuiti C, Macdonald EM, et al. Predictors of opioid-related death during methadone therapy. J Subst Abuse Treat. 2015;57:30–35.
   PubMed Web of Science ®Google Scholar
• Gossop M, Stewart D, Treacy S, Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction. 2002;97:39–47.
   PubMed Web of Science ®Google Scholar
• Walton GR, Hayashi K, Bach P, et al. The impact of benzodiazepine use on mortality among polysubstance users in Vancouver, Canada. Public Health Rep. 2016;131:491–499.
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Mitchell TB, Bond AJ, Nestor L, Strang J. Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients. Drug Alcohol Depend. 2007;91:187–194.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Suwannawong P, Ti L, Kaplan K, Wood E, Kerr T. High rates of midazolam injection and associated harms in Bangkok, Thailand. Addiction. 2013;108:944–952.
   PubMed Web of Science ®Google Scholar
• Dell'osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. Eur Psychiatry. 2013;28:7–20.
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Teesson M, Lynskey M. Health service utilization and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Addiction. 2003;98:1129–1135.
   PubMed Web of Science ®Google Scholar
• Alessi-Severini S, Bolton JM, Enns MW, et al. Use of benzodiazepines and related drugs in Manitoba: a population-based study. CMAJ Open. 2014;2:E208–E216.
   PubMedGoogle Scholar
• Ross J, Darke S, Hall W. Benzodiazepine use among heroin users in Sydney: patterns of use, availability and procurement. Drug Alcohol Rev. 1996;15:237–243.
   PubMed Web of Science ®Google Scholar
• Tyndall MW, Currie S, Spittal P, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17:887–893.
   PubMed Web of Science ®Google Scholar
• Milloy MJ, Kerr T, Buxton J, et al. Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2012;59:393–399.
   PubMed Web of Science ®Google Scholar
• Wood E, Stoltz JA, Montaner JS, Kerr T. Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study. Harm Reduct J. 2006;3:18.
   PubMedGoogle Scholar
• Nosyk B, Marshall BD, Fischer B, Montaner JS, Wood E, Kerr T. Increases in the availability of prescribed opioids in a Canadian setting. Drug Alcohol Depend. 2012;126:7–12.
   PubMed Web of Science ®Google Scholar
• Hayden A, Hayashi K, Dong H, et al. The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort study. BMC Public Health. 2014;14:1153.
   PubMed Web of Science ®Google Scholar
• Nolan S, Hayashi K, Milloy MJ, et al. The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting. Drug Alcohol Depend. 2015 Nov 1;156:57–61.
   PubMed Web of Science ®Google Scholar
• Zivanovic R, Milloy MJ, Hayashi K, et al. Impact of unstable housing on all-cause mortality among persons who inject drugs. BMC Public Health. 2015;15:106.
   PubMed Web of Science ®Google Scholar
• Ciccarone D, Bourgois P. Injecting drugs in tight spaces: HIV, cocaine and collinearity in the Downtown Eastside, Vancouver, Canada. Int J Drug Policy. 2016 Jul;33:26–43.
   Web of Science ®Google Scholar
• Linden IA, Mar MY, Werker GR, Jang K, Krausz M. Research on a vulnerable neighborhood-the Vancouver Downtown Eastside from 2001 to 2011. J Urban Health. 2013;90:559–573.
   Web of Science ®Google Scholar
• Lake S, Hayashi K, Buxton J, et al. The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug Alcohol Depend. 2015;156:297–303.
   PubMed Web of Science ®Google Scholar
• van der Zanden BP, Dijkgraaf MG, Blanken P, de Borgie CA, van Ree JM, van den Brink W. Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug Alcohol Depend. 2006;82:111–118.
   PubMed Web of Science ®Google Scholar
• Ti L, Milloy MJ, Buxton J, et al. Factors associated with leaving hospital against medical advice among people who use illicit drugs in Vancouver, Canada. PLoS ONE. 2015;10:e0141594.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Dong H, Marshall BD, et al. Sex-based differences in rates, causes, and predictors of death among injection drug users in Vancouver, Canada. Am J Epidemiol. 2016;183:544–552.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Nosyk B, Ti L, et al. Increasing availability of illicit drugs among people who inject drugs in Bangkok, Thailand. Drug Alcohol Depend. 2013;132:251–256.
   PubMed Web of Science ®Google Scholar
• Merrall EL, Kariminia A, Binswanger IA, et al. Meta-analysis of drug-related deaths soon after release from prison. Addiction. 2010;105:1545–1554.
   PubMed Web of Science ®Google Scholar
• Binswanger IA, Stern MF, Yamashita TE, Mueller SR, Baggett TP, Blatchford PJ. Clinical risk factors for death after release from prison in Washington State: a nested case-control study. Addiction. 2016;111:499–510.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend. 2009;105:9–15.
   PubMed Web of Science ®Google Scholar
• Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garcia de Olalla P, de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction. 2005;100:981–989.
   PubMed Web of Science ®Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;(3):CD002209.
   PubMed Web of Science ®Google Scholar
• Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011;(8):CD004145.
   PubMed Web of Science ®Google Scholar
• Cousins G, Teljeur C, Motterlini N, McCowan C, Dimitrov BD, Fahey T. Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study. J Subst Abuse Treat. 2011;41:252–260.
   PubMed Web of Science ®Google Scholar
• McCowan C, Kidd B, Fahey T. Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. BMJ Clin Res Educ. 2009;338:b2225.
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Mills K, Teesson M, Williamson A, Havard A. Benzodiazepine use among heroin users: baseline use, current use and clinical outcome. Drug Alcohol Rev. 2010;29:250–255.
   PubMed Web of Science ®Google Scholar